Skip to content

Study of sentinel lymph node for uterine cancer

Study of sentinel lymph node for uterine cancer

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs071200026
Enrollment
540
Registered
2020-08-24
Start date
2020-11-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine cancer uterine cancer

Interventions

In this study, the sentinel lymph node of uterine cancer is identified and biopsied, and the presence or absence of metastasis is diagnosed intraoperatively by cytology and histology, so that reductio

Sponsors

KOBAYASHI Hiroaki
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Cervical cancer FIGO stage IA - IB 1 Endometrial cancer FIGO stage I - II 2. pathological type (cervical cancer) : SCC, adenocarcinoma, adenosquamous cell carcinoma pathological type (endometrial cancer) : endometrioid carcinoma, serous carcinoma, clear cell carcinoma, carcinosarcoma 3. no lymph node swelling (preoperative CT or MRI) 4. patients age : 20age old over 5. ECOG Performance Status, PS: 0 or 1 6. no radiotherapy, chemotherapy and surgery (not including conization) 7. Patients who have no major organs dysfunction 8. Patients who have written consent from the patient

Exclusion criteria

Exclusion criteria: 1. Psychosis or psychiatric symptoms were judged to be difficult to participate in the study 2. Other cases inappropriate judged by medical doctor

Design outcomes

Primary

MeasureTime frame
Complication due to pelvic lymphadenectomy (lower extremity lymphedema, lymphocele, and ileus)

Secondary

MeasureTime frame
1. Operation time, blood loss, transfusion, nerve injury 2. Recurrence rate

Contacts

Public ContactShinichi TOGAMI

Kagoshima University Hospital

togami@m3.kufm.kagoshima-u.ac.jp+81-99-275-5423

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026